ARROWSTREET CAPITAL, LIMITED PARTNERSHIP – Genmab A/S Transaction History
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP portfolio value:
$47.73M
portfolio value
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP quarter portfolio value change:
-1.11%
quarter
Genmab A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.74% | 190.80K shares | 5.66M | $32.13 | 1.48M |
| Q2 2022 | share | Increase | +48.95% | 425.49K shares | 10.61M | $32.49 | 1.29M |
| Q1 2022 | share | Increase | +63.91% | 338.90K shares | 10.46M | $36.18 | 869.22K |
| Q4 2021 | share | Increase | +23.99% | 102.62K shares | 2.28M | $39.86 | 530.31K |
| Q3 2021 | share | Increase | +4355.20% | 418.09K shares | 18.29M | $43.7 | 427.69K |
| Q2 2021 | share | Decrease | -90.36% | -90.03K shares | -2.87M | $40.83 | 9.6K |
| Q1 2021 | share | Decrease | -74.17% | -286.06K shares | -12.41M | $32.83 | 99.63K |
| Q4 2020 | share | Decrease | -19.58% | -93.89K shares | -1.87M | $40.66 | 385.7K |
| Q3 2020 | share | Decrease | -34.28% | -250.17K shares | -7.17M | $36.61 | 479.59K |
| Q2 2020 | share | Increase | +7.59% | 51.46K shares | 10.35M | $33.89 | 729.76K |
| Q1 2020 | share | Increase | +94.12% | 328.88K shares | 6.57M | $21.19 | 678.30K |
| Q4 2019 | share | Increase | +232.45% | 244.31K shares | 5.67M | $22.33 | 349.42K |
| Q3 2019 | share | Increase | 0.00% | 105.10K shares | 2.12M | $20.26 | 105.10K |